- Home
- ICAD vs ANEB Comparison
ICAD vs ANEB Comparison
Compare ICAD & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICAD
- ANEB
- Stock Information
- Founded
- ICAD 1984
- ANEB 2020
- Country
- ICAD United States
- ANEB United States
- Employees
- ICAD N/A
- ANEB N/A
- Industry
- ICAD Medical/Dental Instruments
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- ICAD Health Care
- ANEB Health Care
- Exchange
- ICAD Nasdaq
- ANEB Nasdaq
- Market Cap
- ICAD 40.8M
- ANEB 36.7M
- IPO Year
- ICAD 1986
- ANEB 2021
- Fundamental
- Price
- ICAD $1.68
- ANEB $1.23
- Analyst Decision
- ICAD
- ANEB Buy
- Analyst Count
- ICAD 0
- ANEB 1
- Target Price
- ICAD N/A
- ANEB $8.00
- AVG Volume (30 Days)
- ICAD 337.8K
- ANEB 8.4K
- Earning Date
- ICAD 11-13-2024
- ANEB 02-11-2025
- Dividend Yield
- ICAD N/A
- ANEB N/A
- EPS Growth
- ICAD N/A
- ANEB N/A
- EPS
- ICAD N/A
- ANEB N/A
- Revenue
- ICAD $18,940,000.00
- ANEB N/A
- Revenue This Year
- ICAD $10.15
- ANEB N/A
- Revenue Next Year
- ICAD $3.75
- ANEB N/A
- P/E Ratio
- ICAD N/A
- ANEB N/A
- Revenue Growth
- ICAD 10.03
- ANEB N/A
- 52 Week Low
- ICAD $1.18
- ANEB $1.23
- 52 Week High
- ICAD $2.65
- ANEB $3.30
- Technical
- Relative Strength Index (RSI)
- ICAD 43.66
- ANEB 33.17
- Support Level
- ICAD $1.65
- ANEB $1.30
- Resistance Level
- ICAD $2.13
- ANEB $1.50
- Average True Range (ATR)
- ICAD 0.17
- ANEB 0.13
- MACD
- ICAD -0.00
- ANEB -0.01
- Stochastic Oscillator
- ICAD 6.12
- ANEB 0.00
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.